Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.41 - $2.49 $18,048 - $31,872
12,800 New
12,800 $23,000
Q1 2024

May 15, 2024

BUY
$2.37 - $2.94 $12,087 - $14,994
5,100 Added 182.14%
7,900 $19,000
Q4 2023

Feb 14, 2024

SELL
$2.44 - $3.08 $4,636 - $5,852
-1,900 Reduced 40.43%
2,800 $7,000
Q3 2023

Nov 14, 2023

SELL
$2.63 - $4.26 $12,098 - $19,596
-4,600 Reduced 49.46%
4,700 $12,000
Q2 2023

Aug 14, 2023

BUY
$2.7 - $3.97 $19,440 - $28,584
7,200 Added 342.86%
9,300 $35,000
Q1 2023

May 15, 2023

BUY
$2.06 - $3.18 $824 - $1,272
400 Added 23.53%
2,100 $6,000
Q4 2022

Feb 14, 2023

BUY
$1.88 - $2.4 $3,196 - $4,080
1,700 New
1,700 $3,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $190M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.